This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Pneumonia, Pneumococcal Infections or Streptococcus Pneumoniae Infections
and you are
between 6 and 50
years old
1
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

This study is designed to explore the safety and tolerability of an investigational pneumococcal vaccine through a step-down enrollment. Primary Objective: - To evaluate the safety and tolerability of an investigational pneumococcal vaccine. Secondary Objective: - To evaluate the immunogenicity of an investigational pneumococcal vaccine.

Provided treatments

  • Biological: Pneumococcal Vaccine High Dose (Formulation 1)
  • Biological: Tris buffered saline (Placebo)
  • Biological: Pneumococcal Vaccine High Dose (Formulation 1)
  • Biological: Tris buffered saline (Placebo)
  • Biological: Pneumococcal Vaccine Low Dose (Formulation 2)
  • Biological: Tris buffered saline (Placebo)
  • Biological: Pneumococcal Vaccine Middle Dose (Formulation 3)
  • Biological: Pneumococcal Vaccine Middle Dose (Formulation 4)
  • Biological: Tris buffered saline (Placebo)
  • Biological: Pneumococcal Vaccine High Dose (Formulation 1)
  • Biological: Tris buffered saline (Placebo)

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01446926. The sponsor of the trial is Sanofi Pasteur, a Sanofi Company and it is looking for 280 volunteers for the current phase.
Official trial title:
Safety and Immunogenicity of Pneumococcal Protein Vaccine (PPrV) in Healthy Adults, Toddlers and Infants in Bangladesh